抗细胞毒性T-淋巴细胞关联抗原4(CTLA4)多克隆抗体(异硫氰酸荧光素标记)

FITC-Linked Anti-Cytotoxic T-Lymphocyte Associated Antigen 4 (CTLA4) Polyclonal Antibody

CD152; CELIAC3; CTLA4; GSE; IDDM12; Celiac Disease 3; Cytotoxic T-lymphocyte protein 4

  • 抗细胞毒性T-淋巴细胞关联抗原4(CTLA4)多克隆抗体(异硫氰酸荧光素标记) 产品包装(模拟)
  • 抗细胞毒性T-淋巴细胞关联抗原4(CTLA4)多克隆抗体(异硫氰酸荧光素标记) 产品包装(模拟)
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

用法

For flow cytometry, the suggested use of this reagent is 1-5 μl per 10^6 cells in 100 μl volume.
Optimal working dilutions could be determined by end user.

储存

Store at 4°C, protected from prolonged exposure to light.

赠品

相关产品

编号 适用物种:Homo sapiens (Human,人) 应用(仅供研究使用,不用于临床诊断!)
RPB230Hu01 细胞毒性T-淋巴细胞关联抗原4(CTLA4)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPB230Hu03 细胞毒性T-淋巴细胞关联抗原4(CTLA4)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPB230Hu02 细胞毒性T-淋巴细胞关联抗原4(CTLA4)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPB230Hu04 细胞毒性T-淋巴细胞关联抗原4(CTLA4)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAB230Hu02 细胞毒性T-淋巴细胞关联抗原4(CTLA4)多克隆抗体 WB; IHC; ICC; IP.
PAB230Hu01 细胞毒性T-淋巴细胞关联抗原4(CTLA4)多克隆抗体 WB; IHC; ICC; IP.
FAB230Hu01 抗细胞毒性T-淋巴细胞关联抗原4(CTLA4)多克隆抗体 Flow cytometry.
FAB230Hu41 抗细胞毒性T-淋巴细胞关联抗原4(CTLA4)多克隆抗体(藻红素标记) Flow cytometry.
FAB230Hu51 抗细胞毒性T-淋巴细胞关联抗原4(CTLA4)多克隆抗体(别藻蓝蛋白标记) Flow cytometry.
FAB230Hu81 抗细胞毒性T-淋巴细胞关联抗原4(CTLA4)多克隆抗体(异硫氰酸荧光素标记) Flow cytometry.
MAB230Hu21 细胞毒性T-淋巴细胞关联抗原4(CTLA4)单克隆抗体 WB.
MAB230Hu23 细胞毒性T-淋巴细胞关联抗原4(CTLA4)单克隆抗体 WB; IHC; ICC; IP.
RAB230Hu71 细胞毒性T-淋巴细胞关联抗原4(CTLA4)重组抗体 WB; IF; ICC; IHC; IP; FCM.
MAB230Hu22 细胞毒性T-淋巴细胞关联抗原4(CTLA4)单克隆抗体 WB; IHC; ICC; IP.
MAB230Hu24 细胞毒性T-淋巴细胞关联抗原4(CTLA4)单克隆抗体 WB; IHC; ICC; IP.
MAB230Hu25 细胞毒性T-淋巴细胞关联抗原4(CTLA4)单克隆抗体 WB; IHC; ICC; IP.
MAB230Hu26 细胞毒性T-淋巴细胞关联抗原4(CTLA4)单克隆抗体 WB; IHC; ICC; IP.
MAB230Hu27 细胞毒性T-淋巴细胞关联抗原4(CTLA4)单克隆抗体 WB; IHC; ICC; IP.
SEB230Hu 细胞毒性T-淋巴细胞关联抗原4(CTLA4)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB230Hu 细胞毒性T-淋巴细胞关联抗原4(CTLA4)等多因子检测试剂盒(流式荧光发光法) FLIA Assay for Antigen Detection.
PGB230Hu02 细胞毒性T-淋巴细胞关联抗原4(CTLA4)引物对 PCR

参考文献

杂志 参考文献
Int Immunopharmacol Circulating CTLA-4 levels and CTLA4 polymorphisms associate with disease condition and progression and hepatocellular carcinoma patients' survival in chronic … [Pubmed: 32163858]
留言咨询